Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaling Penehyclidine to Prevent Perioperative Respiratory Adverse Events in Children
NCT06624696Phase 4Completed
- Sponsor
- Sun Yat-sen University
- Start
- Nov 2024
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of penehyclidine in respiratory complication, sponsored by Sun Yat-sen University. Started Nov 2024; status: completed.
02
Drugs
penehyclidine
03
Conditions
respiratory complication
Beyond the preview
Go deeper on NCT06624696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06624696.